Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2014-08-21

FDA Approved: RIFAMPIN — Original Application (Fresenius Kabi USA, LLC)

View source ↗

Summary

FDA approved Fresenius Kabi USA, LLC's generic rifampin (RIFAMPIN) under an Original Application (ANDA), expanding access to this antibiotic.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • RIFAMPIN (RIFAMPIN)

Snippet

ORIG AP for RIFAMPIN (RIFAMPIN)